Atlas Trials

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Clinical trial NCT00002869 · UNKNOWN

Trial details

NCT number
NCT00002869
Sponsor
Medical Research Council
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia
Start date
1995-04-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.